Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis: A Secondary Analysis

IMPORTANCE: Older adults with atopic dermatitis (AD) face unique treatment challenges, including comorbidities, polypharmacy, and a higher risk for infections (eg, herpes zoster). Furthermore, limited data are available from clinical trials for treatments in this population. In phase 3 studies, tral...

Descripción completa

Detalles Bibliográficos
Autores principales: Merola, Joseph F., Butler, Daniel C., Mark, Thomas, Schneider, Shannon, Kim, Yestle, Abuabara, Katrina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448370/
https://www.ncbi.nlm.nih.gov/pubmed/37610789
http://dx.doi.org/10.1001/jamadermatol.2023.2626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448370/
https://www.ncbi.nlm.nih.gov/pubmed/37610789
http://dx.doi.org/10.1001/jamadermatol.2023.2626

Ejemplares similares